Analysis and perspective: Comparison of insulin diluent leakage post-injection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus

Journal of Diabetes Science and Technology

Volumn 6, Issue 2, 2012, Pages 394-395

  Bailey, Timothy S ^a  

^a AMCR Institute Inc   (United States)

Author keywords

Backflow; Insulin injection; Leakage; Needle length

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NEEDLE; NEEDLE LENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; DRUG DELIVERY SYSTEM; FEMALE; INSTRUMENTATION; MALE; NOTE;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE;

EID: 84865144822     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600227     Document Type: Article

References (12)

1. Polonsky WH, Hajos TR, Dain MP, Snoek FJ. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin. 2011;27(6):1169-74.
2. Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care. 2010;33(2):240-5.
3. Frid A, Hirsch L, Gaspar R, Hicks D, Kreugel G, Liersch J, Letondeur C, Sauvanet JP, Tubiana-Rufi N, Strauss K; Scientific Advisory Board for the Third Injection Technique Workshop. New injection recommendations for patients with diabetes. Diabetes Metab. 2010;36 Suppl 2:S3-18.
4. Luijf YM, DeVries JH. Dosing accuracy of insulin pens versus conventional syringes and vials. Diabetes Technol Ther. 2010;12 Suppl 1:S73-7.
5. Bailey T, Thurman J, Niemeyer M, Schmeisl G. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Curr Med Res Opin. 2011;27(10):2043-52.
6. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-30.
7. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, Polak M, Kakou B, Leridon L, Hassan M, Czernichow P. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care. 1999;22(10):1621-5. (Pubitemid 29458383)
8. Wittmann A, Köver J, Kralj N, Gasthaus K, Lerch H, Rommel M, Moses S, Hofmann F. Insulin leakage value in relation to pen needle length and administered dose after subcutaneous injection. Diabetes Technol Ther. 2010;12(8):587-90.
9. Ann Praestmark Juul K, Bengtsson H, Eyving B, Kildegaard J, Lav S, Poulsen M, Serup J, Stallknecht B. Influence of hypodermic needle dimensions on subcutaneous injection delivery - a pig study of injection deposition evaluated by CT scanning, histology, and backflow. Skin Res Technol. 2012. Epub ahead of print.
10. Hirsch LJ, Gibney MA, Albanese J, Qu S, Kassler-Taub K, Klaf LJ, Bailey TS. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010;26(6):1531-41.
11. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther. 2004;26(10):1663-78. (Pubitemid 39643027)
12. Ignaut DA, Fu H. Comparison of insulin diluent leakage postinjection using two diferent needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus. J Diabetes Sci Technol. 2012;6(2):389-93.